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Abstract 
It has been shown previously that ATP is released into extracellular space from pre- and postsynaptic sources in peripheral synapses, 
The extracellular metabolism of ATP is likely to affect nucleotide- and nucleoside-mediated r gulation of neurotransmission. The 
enzymes responsible for ATP breakdown are nucleotidases whose active site faces the extracellular space. ATPase and ADPase 
cae+-dependent ac ivities were characterized in presynaptic plasma membrane preparation from the electric organ of Torpedo. Features 
described were in accordance with the presence of an ATP-diphosphohydrolase (apyrase EC 3.6.1.5) in this fraction. Active site studies 
using the affinity label 5'-fluorosulfonylbenzoyladenosine were performed on Torpedo apyrase. ATPase and ADPase Ca2+-dependent 
activities were inhibited with 5'-fluorosulfonylbenzoyladenosine. From this study it is concluded: (1) 5'-fluorosulfonylbenzoyladenosine 
binds specifically to the active site of apyrase. (2) Divalent cations accelerate the apyrase inactivation rate. (3) Divalent cations are not 
required for the binding of either the substrate or the inhibitor to the active site. (4) The apyrase active site is more specific for highly 
phosphorylated nucleotides. The results presented may be extrapolated toapyrases from other sources. The importance of this enzyme and 
its regulation are discussed. 
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1. Introduction 
The importance of extracellular nucleotides in the regu- 
lation of neurotransmission has been established. ATP is 
packaged and released in a calcium-dependent manner 
together with several neurotransmitters like acetylcholine, 
in both the peripheral and the central nervous system 
[1-3]. Once released, ATP may interact with P2 purinore- 
ceptors [4,5], serves as a substrate for ecto-protein kinases 
[6,7] or be degraded to adenosine via ecto-nucleotidases. 
Adenosine is one of the most important inhibitory modula- 
tors of synaptic transmission in both central and peripheral 
nervous systems, acting presynaptically through P~ puri- 
noreceptors [8-10]. Ecto-nucleotidase activities have been 
Abbreviations: 5'FSO2BzA, 5'-p-fluorosulfonylbenzoyladenosine; 
Me 2 SO, dimethylsulfoxide; PSPM, presynaptic plasma membrane; EDTA, 
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described in synaptosomal preparations either from the 
central [11,12] or the peripheral nervous system [13,14]. 
These enzymes may participate in the control of extracellu- 
lar ATP level in the synaptic cleft and hence in the control 
of purinergic neuromodulation. 
In several synaptosomal fractions, including those from 
Torpedo electric organ, there is evidence for the presence 
of an ecto-ATPdiphosphohydrolase [15]. ATPdiphospho- 
hydrolase (Apyrase EC 3.6.1.5), is a general designation 
for enzymes that hydrolyse /3- and y-bonds of diphospho- 
and triphosphonucleosides [16]. Several features that dif- 
ferentiate these enzymes from other ATP hydrolyzing ac- 
tivities have been specified [13,17]. A number of apyrases 
have been purified, [18-20] but little is known about their 
amino acid sequence, structure or substrate binding site. 
Enzyme inhibitors have been used successfully to describe 
enzyme active sites; however, no specific or efficient 
inhibitor for apyrases has been reported so far. 
5'-Fluorosulfonylbenzoyladenosine (5'FSO 2BzA) is 
considered to be an analogue of ADP and ATP [21 ]. The 
sulfonyl fluoride moiety may be located in a position 
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analogous to the terminal phosphate of ATP and can act as 
an electrophilic agent in covalent reactions with several 
amino acids. Thus, this reagent is especially suitable for a 
specific modification of the purine nucleotide binding sites 
of proteins. Several ATPases, including apyrases, have 
been shown to bind 5'FSO2BzA [22,23]. Hence, 
5'FSO2BzA may be able to modify the Torpedo apyrase 
active site covalently and to inhibit its activity. Studies of 
the active site using affinity analogues of adenosine nu- 
cleotides have yet to be performed on apyrases. 
Torpedo marmorata electric organ is especially appro- 
priate for the study of apyrase in the peripheral nervous 
system, since large amounts of ATP coming from pre- and 
postsynaptic sources have been reported under stimulatory 
conditions [24,25]. Moreover, adenosine depresses acetyl- 
choline release in Torpedo nerve endings [26,27]. 
In the present communication, we demonstrate he pres- 
ence and main features of apyrase activity in a presynaptic 
plasma membrane (PSPM) preparation from the electric 
organ of Torpedo marmorata. The effect of the irre- 
versible inhibitor 5'FSO2BzA on apyrase Ca2+-dependent 
activity in PSPM preparation is also characterized. The 
study of the kinetics of inactivation of Torpedo apyrase by 
5'FSO2BzA may help to understand the general mecha- 
nism of action of apyrases. 
2. Materials and methods 
The following products were obtained from Sigma 
chemical Company (St. Louis MO, USA): 5'FSO2BzA, 
adenosine, AMP, ATP, ADP, GTP, GDP, ITP, IDP, 
p~,pS-di(adenosine-5')pentaphosphate, a,fl-Me-ATP, lev- 
amisole, 2-mercaptoethanol. Ouabain was purchased from 
Boehringer Mannheim (Germany) and 2-glycerophosphate, 
NaN 3 and NaF from Merck (Germany). All general labora- 
tory reagents were of the purest grade available. 
2.1. Animals and obtaining of PSPM 
Torpedo marmorata specimens were caught in the 
Mediterranean sea and maintained alive in artificial sea 
water. Electric organs were dissected out under anaesthesia 
(0.33 g tricaine/l of sea water) (MS222, Sandoz, Basel, 
Switzerland) and immersed in Tris-HC1 10 mM buffer (pH 
7) containing 1 mM EDTA. PSPM were isolated from the 
electric organ according to Morel et al. [28] 
2.2. Enzyme assays and protein determination 
Ca2--nucleotidase activity was determined in 30 mM 
Tris-HC1 (pH 7.7) buffer containing 150 mM NaC1, 5 mM 
KCI, 6.5 mM CaC12, 5 mM EDTA and 1 mM of the 
corresponding ucleotide. Under these conditions 5'nucleo- 
tidase activity has been shown to be inactive [15]. Further- 
more, this incubation medium ensures that Ca 2+ but no 
Mg 2+ nucleotidase activity is measured. When ATP was 
used as a substrate and Mg 2+ as the cosubstrate, ouabain 1 
mM was included in the incubation medium to avoid 
detection of Na /K  ATPase. 
Protein concentration (from 1 to 5 /xg) and incubation 
times were chosen to ensure linearity of the velocity of 
product formation with a final hydrolysis of 2-3% of 
substrate. The reaction was stopped by the addition of 
trichloracetic acid 5% (mass/V) final concentration. Free 
phosphate was determined by the method of Lanzetta et al. 
[29] with KH2PO 4 as a reference standard. Blanks were 
determined by incubation of parallel samples in the same 
buffer lacking Ca 2+ and/or Mg z+. 
Na/K  ATPase activity (EC 3.6.1.37) [30] was assessed 
in Tris-HC1 30 mM (pH 7.7) buffer containing 150 mM 
NaCI, 5 mM KC1, 5 mM EDTA, 6.5 mM MgCI 2 and 1 
mM ATP. Blanks for Na /K  ATPase activity were deter- 
mined in the same buffer but in the presence of 1 mM 
ouabain. Na /K  ATPase activity was calculated as the 
difference between the ouabain-insensitive and ouabain- 
sensitive activity. 
5'Nucleotidase (EC 3.1.3.5) [31] was evaluated in 30 
mM Tris-HC1 (pH 7.7) buffer containing 150 mM NaC1, 5 
mM KC1, 6.5 mM MgCI z and 1 mM AMP. Blanks for 
5'nucleotidase activity were determined in the same buffer 
in the presence of 5 mM EDTA and the absence of MgCI 2. 
One unit of enzyme activity is defined as the amount of 
enzyme that releases 1 nmol Pi/min at 23°C under the 
conditions pecified above. Data are mean + standard e- 
viation from at least three experiments. 
Protein was determined by the method of Bradford [32] 
using bovine serum albumin as standard. 
2.3. Reaction of 5'-p-fluorosulfonylbenzoyladenosine with 
presynaptic plasma membrane Ca 2 +-ATPase and Ca e +- 
ADPase activities 
Enriched presynaptic plasma membrane fraction at a 
protein concentration f 0.5 mg/ml was incubated at 30°C 
with 5'FSOEBzA in the presence and in the absence of 
several nucleotides. 
PSPM were diluted in l0 mM Tris-HCl (pH 7.4) con- 
taining 1% (v/v)  Me 2 SO. Inclusion of the organic solvent 
increased the solubility of 5'FSO 2 BzA. 
During the reaction, aliquots were withdrawn at given 
time intervals, diluted 8-fold with Tris-HCl (pH 7.4) buffer 
at 4°C and immediately pelleted by centrifugation at 
10000 × g. Under such conditions the probability of addi- 
tional reaction between the reagent and the protein was 
insignificant. Membranes were washed three times in the 
same buffer to remove unbound reagent. ATPase and 
ADPAse activities were then assayed. 
Semilogarithmic plots of V/V o versus time were linear. 
V and V 0 are specific activities at a given time either in the 
presence or absence of 5'FSOEBzA (control conditions). 
Data are mean + standard eviation from at least three 
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experiments. Statistical differences between groups were 
established using nonparametric Kurskal-Wallis (analysis 
of variance) and Mann-Whitney test. 
3. Results 
3.1. Nucleotidase activities associated with presynaptic 
plasma membranes 
The PSPM fraction was extremely rich in 5'-nucleo- 
tidase and Na/K  ATPase activities, 74.7 __+ 11 and 412 _ 
54 (U/mg of protein) respectively. Ca-dependent ucleo- 
tidase activity was also highly represented in this fraction. 
Ca2+-dependent ucleotidase activities from PSPM 
fraction were characterized. Michaelis-Menten constants 
for the hydrolysis of ATP and ADP in the presence of 
supramaximal concentrations of CaC12 were (/zM) 46 + 9 
and 48 +_ 10 respectively. Maximal velocities (U /mg of 
protein) calculated were 47 + 9 and 34 + 5 respectively. In
the presence of supramaximal concentrations of MgC12, 
maximal velocities of 70 _ 14 for ATPase and 43 + 7 for 
ADPase were found. No additive effect was observed 
when the activity was measured in the presence of both 
CaC12 and MgCI 2 together with ATP (49+ 7 U /mg 
protein) or ADP (50 + 10 U /mg protein), suggesting that 
a single enzyme may be activated by either Ca 2÷ or Mg 2÷ 
independently. 
A mixed-substrate kinetic approach was performed in 
order to identify a possible association of two separate 
ATPase and ADPase activities. PSPM were incubated in a 
medium containing 1 mM ATP (5 mM CaC12), 1 mM 
ADP (5 mM CaC12) or 1 mM ATP + 1 mM ADP (10 mM 
CaCi2). In the simultaneous presence of both substrates 
the rate of Pi production (in U /mg of protein) of 38 + 6 
was very close to the arithmetic mean (36) of those 
activities obtained with ADP (32 + 8) and ATP (40 __+ 13) 
Table 1 
Calcium-dependent nucleotidase activity in presynaptic plasma mem- 
branes 
Substrate Relative velocity 
ATP 1 
ADP 0.66 
GTP 0.67 
GDP 0.64 
CTP 1.26 
CDP 0.67 
ITP 0.99 
IDP 0.85 
AMP n.d 
2-glycerophosphate n.d 
PSPM nucleotidase activity was assayed under stimulatory conditions, 
i.e., Tris-HCl (pH 7.7) containing 6 mM, CaC12, 5 mM EDTA and 1 mM 
of the indicated nucleotide as described in Section 2. The relative velocity 
is calculated as the nucleotide/ATP hydrolysis ratio. Data represent the 
average of three experiments, n.d., not detected. 
Table 2 
Effect of various inhibitors in Ca2+-ATP and Ca2+-ADP hydrolysis by 
presynaptic plasma membranes 
Inhibitor % of activity remaining 
Ca 2 +-ATPase Ca" +-ADPase 
None 100 100 
NaN 3 (20 mM) 62 41 
NaN 3 (1 mM) 93 92 
NaF (20 mM) 62 62 
NaF (1 mM) 93 90 
2-Mercaptoethanol (5 mM) 94 89 
Levamisole (1 mM) 98 97 
p l, pS-Di(adenosine-5')penta- 98 95 
phosphate (10/.tM) 
Ouabain (1 raM) 89 96 
Values of 100% of nucleotidase activities refer to 46.7 and 36.5 U/mg of 
protein for ATP and ADP substrates respectively. All the inhibitors tested 
were preincubated 5 min with PSPM. Remaining activities were calcu- 
lated as a percentage of control activity. Data represent the average of 
three experiments. 
when incubated individually. An additive effect would be 
expected if two separate nzymes were present. 
Ca2+-dependent hydrolysis of several nucleotides tri-, 
di- and monophosphate was analyzed (Table 1). Little 
substrate hydrolysis specifity was observed, suggesting 
low specificity for the type of nucleoside. No free phos- 
phate was detected when AMP was used as a substrate. 
2-Glycerophosphate hydrolysis was not detected, indicat- 
ing that non-specific phosphatases are poorly represented 
in the subcellular fraction of PSPM. 
Results shown in Table 2 summarize the effect of 
several known ATPase inhibitors on PSPM Ca2+-depen - 
dent ATPase and ADPase activities. At concentrations of
N3Na and NaF sufficient o inhibit mitochondrial ATPase 
and alkaline phosphatase r spectively, no effect was ob- 
served on ATPase or ADPase from PSPM. When we 
increased sodium azide concentration up to 20 mM, an 
inhibition of 37% and 58.5% was observed for ATPase 
and ADPase Ca2÷-dependent activities respectively. When 
20 mM NaF was used, 37% of the inhibitory effect on both 
activities was found. The amount of free phosphate de- 
tected when ADP is used as a substrate is not altered in the 
presence of p~,phdi(adenosine-5')pentaphosphate, an in- 
hibitor of adenylate kinase [33], suggesting that no ADP 
was hydrolysed with the participation of an adenylate 
kinase and ATPase association. Lanthanum, a 
(Ca 2 +/Mg ~ +) ATPase inhibitor [34], also had no effect on 
ATPase and ADPase activities from PSPM. The alkaline 
phosphatase inhibitor levamisole [35] and 2-mercapto- 
ethanol did not modify ATPase or ADPase activities in our 
preparation. Ouabain, a specific inhibitor of Na+/K  + 
ATPase [36] did not have any effect on CaZ+-dependent 
ATPase or ADPase activities. However, it should be noted 
that only 39% of the Mg2+-dependent ATPase was 
ouabain-insensitive in our preparation. 
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3.2. Reaction of 5'FSO2BzA with ADPase and ATPase 
activities 
The kinetics of inhibition of nucleotidase activity in the 
presence of calcium by 5'FSO2BzA were analyzed. Since 
several ATPases may be present in PSPM, ADP was 
chosen as the most specific substrate to study apyrase 
activity. Therefore the inhibitory effect of 5'FSO 2 BzA on 
ADPase activity was studied first. 
ADPase activity of PSPM, at a protein concentration of
0.5 mg/ml,  was inactivated upon incubation with 
5'FSO2BzA at 30°C in Tris-HC1 10 mM (pH 7.5) buffer. 
The time course of Ca 2 +-dependent ADPase activity in 
the presence of 5'FSO2BzA is presented in Fig. 1. Inacti- 
vation of ADPase activity reached its maximal effect of 
75% inhibition after 90 min incubation with 1 mM 
5'FSO2BzA. No further decrease in ADPase activity was 
observed when incubation was prolonged for up to 120 
min or when reagent concentration was increased up to 2 
mM. 
The decrease in Ca2+-ADPase activity obeyed pseudo- 
first order kinetics. A plot of the natural ogarithm of the 
residual enzyme activity as a function of the reaction time 
(Fig. 2), allowed for the calculation of the pseudo-first 
order constant (Kob ~) from the slope at every reagent 
concentration, using the equation: 
- ln (  V/Vo) = Kob~.t 
At 1 mM 5'FSO2BzA, an apparent first order rate constant 
of 0.0924 ___ 0.012 min -1 was calculated. To establish a 
reversible binding of the reagent o the enzyme prior to 
covalent modification, the Kob ~ at different 5'FSO2BzA 
concentrations were calculated [37]. The plot of the first- 
order rate constants as a function of 5'FSOzBzA concen- 
tration between 0.1 and 2 mM exhibited saturation kinetics 
(Fig. 3). The double reciprocal plot of these data (Fig. 3, 
inset), based on the equation: 
1/Kob~.= 1/K  2 + K i /K  2 • [I] 
gave a value of K i of 1.1 + 0.2 mM, which represented 
the concentration of the reagent giving half maximal inac- 
tivation rate. The initial formation of a reversible complex 
between the reagent and the enzyme is demonstrated, since 
the line does not pass through the origin showing positive 
intersection on the abscissa (P  < 0.05, n = 4) [37]. Grad- 
ual development of irreversible inhibition is reported by a 
K 2 of 0.175 + 0.03 min, which illustrates the maximal rate 
of inhibition at saturating concentrations of the reagent. 
The inhibition of ATPase activity by 5'FSO2BzA was 
also examined. The kinetics of inactivation was very simi- 
lar to that described for ADPase activity (data not shown). 
Calculated Kob ~ at 1 mM 5'FSO2BzA concentration was 
0.115 _ 0.027 min - 1 and a K i of 2 mM was found. The 
nearly identical behavior of both activities in the presence 
of the reagent supports the idea that most of the Ca2+-de - 
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Fig. 1. Time course of Ca2+-ADPase activity inhibition by 1 mM. 
5'FSO2BzA. PSPM at a protein concentration of 0.5 mg/ml  were 
incubated in the presence and in the absence (control) of the reagent at 
30°C in Tris-HC1 10 mM (pH 7.4) buffer containing 1% (v/v)  Me2SO. 
At the indicated times an aliquot was removed and the activity was 
assayed as described in Section 2. Residual activity was calculated from 
the ratio of the measaured enzymatic activity for the reaction at the 
indicated time (V), to the measured enzyme activity for the correspond- 
ing control reaction (Vo). The kinetic of inactivation follows an exponen- 
tial decay. Each point represents he average of at least 3 determinations, 
and the error bars show the standard eviation. 
pendent nucleotidase activity measured was due to a single 
enzyme i.e., apyrase. 
3.3. Effect of substrates and other reagents on inactivation 
by 5'-p-fluorosulfonylbenzoyladenosine 
We tested the specificity of 5'FSO2BzA-mediated inhi- 
bition by measuring the ability of several igands to pre- 
vent the 5'FSO 2 BzA inhibition of putative apyrase activity 
(Table 3). Different reagents were incubated together with 
5'FSO2BzA over the time period (60 min) required to 
block about 75% of the activity. 
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Fig. 2. Representative experiment of determination of the pseudo-first 
order rate constant from the decreased observed Ca2+-ATPase velocity 
(left panel) and Ca2+-ADPase velocity (right panel). PSPM were incu- 
bated at different concentrations of 5'FSO 2 BzA: 0.25 mM (triangles), 0.5 
mM (squares), 0.75 mM (diamonds), 1 mM (circles). Residual activity 
was determined as described in the legend to Fig. 1. The rate constant is 
determined from the slope of the natural logarithm of the residual enzyme 
activity plotted against ime. 
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Table 3 
Effect of potential protecting agents on inactivation of Ca2+-dependent 
nucleotidase activity by 5'-FSO2BzA 
Additions to reaction mixture Percent residual activity 
Ca 2 +-ATPase Ca 2 +-ADPase 
None 30 28 
Adenine nucleotides 
ATP (10 mM) 100 102 
ADP (10 mM) 101 105 
AMP (10 mM) 97 100 
Adenosine (10 mM) 58 55 
ATP (10 mM)+Ca 2+ (10 mM) 108 107 
ATP (10 mM)+Mg 2+ (10 mM) 100 99 
ADP (10 mM)+Ca 2+ (10 mM) 107 105 
ADP (10 mM)+Mg 2+ (10 mM) 106 98 
Divalent cations 
Ca 2÷ (10 mM) 28 26 
Mg 2÷ (10 mM) 26 26 
Chelators 
EDTA (2 mM) + EGTA (2 mM) 35 27 
P2x-agonists 
a,/3-Me ATP (1 raM) 108 97 
Suramin (10 mM) 85 63 
PSPM Ca 2+ dependent nucleotidase activity was inactivated with 1 mM 
5'-FSO2BzA at 30°C, in Tris-HC1 10 mM (pH 7.4) buffer containing 1% 
(v/v)  Me2SO. Potential competitors were added together with 5'- 
FSO2BzA. Aliquots were removed after 1 h incubation and residual 
enzymatic activity was assayed. Percentage of residual activity was 
calculated by comparing the activity under the different reatments with 
the activity under control conditions; i.e., in the absence of possible 
competitors. Adenosine and adenosine derivatives were incubated to- 
gether with EDTA and EGTA (2 mM) when used as protective reagents. 
Values are the average of one least of three experiments. 
Both ATP and ADP were able to displace 100% of 
5'FSO2BzA inhibitory effect when used at a final concen- 
tration of 10 mM in the presence of EDTA and EGTA 
Table 4 
Effect of different reagents on rate constant for inactivation by 5'- 
5' FSO 2 BzA 
Ligand added to the 
reaction mixture 
Kob ~. (X 103) min -  1 
Ca 2 +-ATPase Ca 2 + -ADPase 
None 91 103 
Nucleotides 
ATP (10 raM) 0 0 
ADP (10 raM) 0 0 
ATP (0.2 mM) 55 58 
ADP (0.2 raM) 65 64 
Divalent cations 
Ca 2÷ (10 mM) 154 153 
Mg 2÷ (10 mM) 123 153 
PSPM were incubated with 1 mM 5'FSO2BzA in the presence and 
absence of different ligands. Aliquots were removed in the course of the 
reaction and inactivation rate constant was calculated as described in Fig. 
3. 
chelators. This result suggested that divalent cations may 
not be necessary for substrate recognition of the active site, 
but may be needed for both ATP and ADP hydrolysis. 
This could be extrapolated to the structural analogue 
5'FSO2BzA since the presence of EDTA and EGTA chela- 
tors removing trace concentrations of divalent cations in 
the incubation medium did not modify the degree of 
inhibition of apyrase. 
Divalent cations (10 mM) alone did not elicit any 
protection from 5'FSO2BzA inactivation (Table 3); how- 
ever, the inactivating reaction was 48% faster in the pres- 
ence of high concentrations of CaC12 and MgC12. A 
similar result was obtained when ATPase inhibition reac- 
tion was evaluated (Table 4). 
Other purine and pyrimidine nucleotides di- and 
triphosphate, which are natural substrates of the broad 
.2 
I 
.c_ 
E • 
v 
.i • o 
o X-" 
0 I I I I 
0.5 1.0 1.5 2.0 
[5'-FSBA] mM 
Fig. 3. Pseudo-first order rate constants of inactivation of Ca2+-ATPase (closed circles) and Ca2+-ADPase (open circles) as a function of 5'FSO2BzA 
concentration. Kob s were determined at different 5'FSO 2 BzA concentrations a described in the legend to Fig. 1. The inset is a double reciprocal plot of 
these data. From this plot K i and K 3 are calculated. 
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Fig. 4. Relative ability of nucleotides in protecting from 5'FSO2BzA 
inhibition of Ca2+-ATPase (filled bars) and Ca2--ADPase (open bars). 
PSPM at a protein concentration of 0.5 mg/ml were incubated with 1 
mM 5'FSO2BzA together with the indicated nucleotide at 0.5 mM final 
concentration. After 1 h incubation, samples were extracted, pelleted and 
washed as indicated in Section 2. Residual activity was then determined. 
Each bar is the mean and the standard eviation of three determinations. 
Asterisks indicate significant differences with control activities, i.e., in 
the absence of competing nucleotides. (P < 0.05, n = 4). 
non-specific nucleotidase activity, i.e., ITP, IDP, GTP, 
GDP, UTP and UDP, were also able to prevent 5'FSO2BzA 
inhibition of ATPase and ADPase activities when used at 
10 mM in the presence of EDTA and EGTA chelators 
(data not shown). 
c~,/3-Methylene ATP, a P2 purinergic receptor agonist, 
was able to protect apyrase 5'FSO2BzA-mediated inhibi- 
tion at a concentration of 1 mM. Suramin, another P2 
receptor agonist, is also known to inhibit several ATPases 
reversibly [38,39]. This reagent prevented most of 
5'FSO2 BzA-mediated inhibition. 
AMP 10 mM also displaced 100% ATPase and ADPase 
inhibition, while adenosine, at the same concentration, 
only partially protected nucleotidase from the effect of 
5'FSO 2 BzA, suggesting that the active site may have more 
affinity for nucleotides than nucleosides. AMP is not a 
substrate but a product of apyrase activity. A possible 
inhibitory effect of the reaction product on apyrase was 
also examined. ATPase and ADPase activities were 50% 
inhibited by 10 mM AMP. 
The relative ability of adenosine nucleotides to prevent 
5'FSO2BzA effect was studied. Both ADP and ATP were 
able to protect apyrase inhibition significantly at 0.3 mM 
(P  < 0.05, n = 4), while higher concentrations of AMP 
were necessary for that purpose. Fig. 4 illustrates the 
ability of adenosine nucleotides to displace the 5' FSO 2 BzA 
effect at 0.5 mM. 
4. Discussion 
The relevance of ecto-apyrases in the regulation of 
neurotransmission is an unsolved problem in neuronal 
systems. However, it has been shown recently that all the 
presynaptic depression observed in frog neuromuscular 
junction is due to the release of adenosine derivatives [10]. 
This could be extrapolated to the electric organ of Tor- 
pedo, considered to be homologous to the neuromuscular 
system. In this preparation high extracellular ATP levels 
coming from pre- and postsynaptic sources have been 
detected, which may be substrates for ecto-apyrase. The 
adenosine resulting from ecto-5'nucleotidase activity is 
believed to be the effector in retroinhibitory control of 
transmitter release [27]. Full understanding of the puriner- 
gic regulation of neurotransmission relies partially on the 
comprehension f the mechanisms of action of apyrase. 
The specific Ca2+-dependent ATPase and ADPase ac- 
tivities found in PSPM preparation are 5 times higher than 
those reported in the synaptosomal fraction [15]. The ratio 
of ATP/ADP Ca2+-dependent hydrolysis of 1.3 is kept 
constant from synaptosomal preparation to PSPM, indicat- 
ing that both activities copurified in this fraction. There- 
fore, the enzymatic activities that we have measured may 
represent the ecto-apyrase activities previously reported in 
isolated nerve terminals. 
In the present study, calcium was chosen as cosubstrate 
since it is probably one of the physiological activators in 
the synaptic cleft and because our results suggested the 
presence of several Mg:+-ATPases. ADPase activity was 
15% higher active when the cosubstrate used was Mg 2÷, 
while ATPase activity was 33.5% increased even in the 
presence of ouabain. Thus Mg 2+ may activate other AT- 
Pases. 
The low K m values obtained for Ca2+-ATP and for 
Ca2+-ADP are in close agreement with K m of other 
synaptosomal ecto-nucleotidase characterizations [13,40]. 
Similar K m values for both substrates are characteristic of
apyrases [ 18]. 
In PSPM, we have ruled out the possibility that apyrase 
activity measured under our assay conditions is the conse- 
quence of different enzyme combinations. The association 
of an ATPase and an ADPase is excluded by the mixed 
substrate xperiment, which is a classical procedure for the 
characterization f apyrase enzymes [15,18,41,42]. Addi- 
tionally non-specific phosphatases are negligible since no 
activity could be detected using 2-glycerophosphate as a 
substrate. 
In summary, in PSPM preparation from Torpedo elec- 
tric organ there is at least one nucleotidase activity that 
fulfils the typical characteristics described for apyrase 
enzyme: low substrate specificity toward purine and 
pyrimidine nucleotides, activation by either Ca 2 ÷ or Mg 2÷ 
as a cosubstrate, low K m for the nucleoside di- and 
triphosphate and lack of inhibition by typical inhibitors of 
other ATPases except for high concentrations of fluoride 
and azide [13,17]. Moreover, we have shown that 
calcium-dependent nucleotidase activity determined under 
our assay conditions in PSPM fraction is due to apyrase 
activity. Thus the effect of 5' FSO 2 BzA was measured on 
CaZ+-ATPase and CaZ+-ADPase activities. 
5'FSO2BzA behaves as a specific site-directed reagent 
in our preparation since the analysis of its reaction accom- 
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plishes two necessary criteria [21]. First, the rate of inacti- 
vation plotted as function of the reagent concentration 
rather shows saturation kinetics, providing kinetic evidence 
for the initial formation of a reversible complex prior to 
covalent irreversible inactivation. Second, the presence of 
natural purine nucleotides decreases the rate of inactivation 
by the reagent when used at low concentrations; higher 
concentrations of the nucleotides and reversible inhibitors 
totally abolish the inactivation rate. 
Several proposals can be made both about the mecha- 
nism of hydrolysis and the active site of the enzyme from 
the analysis of 5'FSO2BzA-mediated inhibition and dis- 
placement experiments. Divalent cations, which are neces- 
sary for the hydrolysis of nucleotides di- and triphosphate, 
are not needed for the recognition and binding of the 
substrate to apyrase active site. Natural substrates have 
been shown to displace 5'FSO2BzA-mediated inhibition 
even in the presence of divalent cations chelators uch as 
EDTA and EGTA. Additionally, 5'FSO2BzA covalently 
modifies apyrase in the presence of both EDTA and 
EGTA, supporting the preceding suggestion. Our conclu- 
sions agree with the results obtained in ecto-ATPase char- 
acterization from mammalian synaptosomes [11]. 
Ca 2+ and Mg 2+ did not modify the maximal degree of 
inhibition of apyrase after 1 h incubation with 5'FSO2BzA; 
however, these ions significantly increased the inactivation 
rate. These results are consistent with those obtained in 
studies on the active site of cyclic AMP-dependent protein 
kinase [43]. Those authors suggested the possibility that 
the cations formed complexes with 5'FSO2BzA that were 
more potent inhibitors of the enzyme. This could be ex- 
trapolated to the natural substrate, as it has been previously 
shown that metal ions can form complexes with the purine 
ring as well as phosphate groups of nucleotides [44]. 
Otherwise metal cations could also form complex with the 
enzyme, improving the binding of both the reagent and the 
substrate to the active site. 
According to the protection experiments, the active site 
seems to exhibit greater specifity for highly phospho- 
rylated nucleotides. At high concentrations, adenosine is 
not able to displace 100% of 5'FSO2BzA effect, while 
AMP is able to do so. Thus the monophosphate moiety is 
sufficient o protect from the effect of 5'FSO2BzA. More- 
over, ATP and ADP significantly displace the effect of 
5'FSOzBzA at a similar concentration, while AMP pro- 
tects only at higher concentrations. 
We have demonstrated that 5'FSO2BzA is an effective 
inhibitor of apyrase activity compared with specific AT- 
Pase inhibitors. In the future, 5'FSO2BzA may be a useful 
tool to identify the purine nucleotide site of Torpedo 
apyrase. 
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